ASX Announcements

Archive
22 June 2022

Investor Presentation - Gold Coast Investment Showcase

Living Cell Technologies' Chief Operating Officer, Dr Belinda Di Bartolo, presented an update on LCT's third clinical trial of NTCELL in Parkinson's disease at the Gold Coast Investment Showcase conference.

21 June 2022

LCT Presenting at Gold Coast Investment Showcase

Living Cell Technologies invites investors to attend the Gold Coast Investment Showcase, to be held from 22-23 June at JW Marriott Gold Coast Resort & Spa, Qld. LCT's COO, Dr Belinda Di Bartolo, will provide an investor update from 3.30pm AEST Wednesday.

8 June 2022

Change of Director's Interest Notice - C Sue

Change of Director's Interest Notice for Non-Executive Director, Professor Carolyn Sue.

6 June 2022

Change of Director's Interest Notice - R Willcocks

Change of Director's Interest Notice for Non-Executive Director, Mr Robert Willcocks.

3 June 2022

Application for Quotation of Securities - LCT

Application for the quotation of 257,000,000 LCT securities, issued as part of a placement.